Abstract
SNAP-25 immunoreactivity was translocated into the endings of the processes induced in PC12 cells by dibutyryl-cAMP-treatment. Conversely, the protein was not present in the endings of the processes seen after NGF-treatment unless dibutyryl-cAMP was used simultaneously. This redistribution of SNAP-25 immunoreactivity appeared to be dependent upon new protein synthesis. Finally, dibutyryl-cAMP was capable of inducing SNAP-25 expression.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adrenal Gland Neoplasms / physiopathology
-
Animals
-
Axons / drug effects
-
Axons / physiology*
-
Bucladesine / pharmacology*
-
Cell Differentiation
-
Cell Line
-
Membrane Proteins*
-
Nerve Growth Factors / pharmacology
-
Nerve Tissue Proteins / metabolism*
-
Pheochromocytoma / physiopathology
-
Synaptosomal-Associated Protein 25
Substances
-
Membrane Proteins
-
Nerve Growth Factors
-
Nerve Tissue Proteins
-
Synaptosomal-Associated Protein 25
-
Bucladesine